Blank, S. V., Christos, P., Curtin, J. P., Goldman, N., Runowicz, C. D., Sparano, J. A., . . . Muggia, F. M. (2010). Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment. Gynecologic oncology, 119(3), 451-456. https://doi.org/10.1016/j.ygyno.2010.08.008
Citace podle Chicago (17th ed.)Blank, Stephanie V., Paul Christos, John P. Curtin, Noah Goldman, Carolyn D. Runowicz, Joseph A. Sparano, Leonard Liebes, Helen X. Chen, a Franco M. Muggia. "Erlotinib Added to Carboplatin and Paclitaxel as First-line Treatment of Ovarian Cancer: A Phase II Study Based on Surgical Reassessment." Gynecologic Oncology 119, no. 3 (2010): 451-456. https://doi.org/10.1016/j.ygyno.2010.08.008.
Citace podle MLA (9th ed.)Blank, Stephanie V., et al. "Erlotinib Added to Carboplatin and Paclitaxel as First-line Treatment of Ovarian Cancer: A Phase II Study Based on Surgical Reassessment." Gynecologic Oncology, vol. 119, no. 3, 2010, pp. 451-456, https://doi.org/10.1016/j.ygyno.2010.08.008.